---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-048251"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2025-11-03T23:59:59+00:00"
generated_at: "2026-05-17T01:02:12.601434+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medifast Q3 revenue down 36% to $89.4M; net loss $2.3M; coaches drop 35%

## Summary
- Revenue $89.4M vs $140.2M YoY; net loss $0.21 per diluted share vs $0.10 income.
- Active earning OPTAVIA coaches fell to 19,500 from 30,000, due to GLP-1 competition.
- Gross margin 69.5% vs 75.4% on fixed-cost de-leverage and $180 basis pts for product reformulation.
- Q4 2025 guidance: revenue $65M–$80M; diluted loss per share $0.70–$1.25.
- Cash & investments $173.5M; no debt.

## SEC filing metadata
- accession: 0001628280-25-048251
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2025-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828025048251/0001628280-25-048251-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828025048251/med-20251103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-048251
- JSON: https://secwatch.observer/filing/0001628280-25-048251.json
- Plain text: https://secwatch.observer/filing/0001628280-25-048251.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.